NCT07022704 Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial
| NCT ID | NCT07022704 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 35 participants |
| Start Date | 2025-06-22 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 35 participants in total. It began in 2025-06-22 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers aim to evaluate the impact of doxapram administration on diaphragmatic excursion in chronic obstructive pulmonary disease (COPD) patients undergoing spontaneous breathing trial
Eligibility Criteria
Inclusion Criteria: * Patients with moderate to severe chronic obstructive pulmonary disease undergoing spontaneous breathing trial Exclusion Criteria: * Refusal Allergy to doxapram neuromuscular disorders inability to evaluate the diaphragm
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07022704 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07022704 currently recruiting?
Yes, NCT07022704 is actively recruiting participants. Contact the research team at dr_mina20002010@yahoo.com for enrollment information.
Where is the NCT07022704 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07022704 clinical trial?
NCT07022704 is sponsored by Cairo University. The trial plans to enroll 35 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.